Soquelitinib clinical development for atopic dermatitis advancing with Phase 1 cohort 4 positive data and initiation of Phase 2 trial during the ...
The Fund seeks daily investment results, before fees and expenses, of 300% of the daily performance of the Financials Select Sector Index. The Fund, under normal circumstances, invests at least 80% of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results